2025 pricing data for benchmarking and informed decision-making
Regional breakdown of pricing: Americas, Europe, APAC
Over 40 profiles of biologics CDMOs specializing in microbial fermentation
Deep focus into microbial cell culture-based therapeutics, such as cytokines and growth factors
Emerging trends and technologies shaping the future of the market
Unlock the biologics market with insights into manufacturing trends and a comprehensive study of the top CDMOs specializing in microbial fermentation of therapeutics. Benchmark your business from development to manufacture with our in-depth pricing studies, which use years of primary data.
Our Market Insight report provides unique analyses into biologics produced in microbial cell culture, such as cytokines and growth factors. Hear from PhD scientists, KOLs, and respected market voices as they discuss developing microbial fermentation-based biologics and the disruptive technologies forging the future of healthcare.
Competitive benchmarking of pricing and capabilities for companies all over the world, broken down by global region
Over 40 profiles of CDMOs specializing in microbial fermentation
Scientific analysis of the clinical trials for insulin and GLP-1 agonists, including format, sponsors, and indications
Unique benefits and complexities to microbial fermentation-based biologics
Market growth projections for the biologics market, with distinct therapeutic segments such as cytokines and growth factors
Investment outlook analyzing economic and regulatory conditions
Over 1,000 hours of data collection and analysis —
including interviews with CDMO owners, PhDs and customers.